Experience
Alzheimer's Institute of America, Inc.
Eli Lilly and Company
Represented Eli Lilly in suit concerning technology used in searching for drugs to treat Alzheimer's disease. Obtained dismissal with prejudice based on lack of standing; also obtained a finding of exceptional case, entitling client to an award of attorneys' fees.
Alzheimer's Institute of America, Inc. v. Eli Lilly and Company, 3:10-cv-00482, N.D. Cal., Judges Breyer, James, Laporte
Hospira, Inc. v. Eli Lilly and Co.
Eli Lilly and Co.
Eli Lilly and Company v. Genentech, Inc.
Eli Lilly and Company
Chiron Corp. v. Eli Lilly and Vertex Pharmaceutical
Eli Lilly and Vertex Pharmaceuticals
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Eli Lilly and Company
Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals
Avid Radiopharmaceuticals
Eli Lilly and Company v. Actavis Labs. UT Inc.
Eli Lilly and Company
Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.
Eli Lilly and Co.; ICOS
Eli Lilly and Co. v. Apotex Inc.
Eli Lilly and Company
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.